GoldenGolden
Serum Institute of India

Serum Institute of India

Serum Institute of India is a company that manufactures vaccines and other pharmaceutical products

Serum Institute of India is a company that manufactures vaccines and other pharmaceutical products. The company was founded in 1996 in Pune, Maharashtra, India.

Serum Institute of India claims to be the largest vaccine manufacturer by number of doses. They have produced and sold over 1.5 billion doses of vaccines around the world. The company has manufacture vaccines for Polio, Diphtheria, Tetanus, Perussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, and Rubella diseases.

COVID-19

With the outbreak of COVID-19 (coronavirus), Serum Institute of India has claimed to have found a breakthrough in developing a vaccine for the contagion. Their virus-vaccine strain has reached animal clinical trial stages. They expect results from these trials within two months.

The company has partnered with a US-based biotech drug research company, Codagenix, to develop a vaccine to fight the coronavirus. The company claims it is the first vaccine to move from the laboratory to pre-clinical trial phase and they expect the product to be ready by 2022.

Timeline

April 28, 2021
Serum Institute of India announces that it was reducing the price of its Covishield vaccine for state governments from Rs 400 to Rs 300 per dose as a "philanthropic gesture".

People

Name
Role
LinkedIn

Adar Poonawalla

CEO

Cyrus Poonawalla

Managing Director

Further reading

Title
Author
Link
Type
Date

About Serum Institute Of India Pvt. Ltd.

Web

Serum Institute of India | Manufacturer of Vaccines & immuno-biologicals - GMP Vaccine Manufacturer

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Serum Institute of India

Adar Poonwalla

Pune, Maharashtra, India

Biotechnology, pharmaceuticals

News

Title
Author
Date
Publisher
Description
By ANIRUDDHA GHOSAL
June 18, 2021
AP NEWS
NEW DELHI (AP) -- Starting Monday, every Indian adult can get a COVID-19 vaccine dose for free that was purchased by the federal government. The policy reversal, announced by Prime Minister Narendra Modi last week, ends a complex system of buying vaccines that worsened inequities in administering the shots.
Divya Rajagopal
June 16, 2021
mint
SII is unlikely to launch jab by September due to delay in receiving bioreactor bags, enzymes
Sohini Das
June 14, 2021
@bsindia
On track to make 100 mn doses per month by Q3 of 2021
June 13, 2021
The Economic Times
Several private hospitals across the country said they have no clarity on procuring COVID-19 vaccines under the new policy announced by Prime Minister Narendra Modi and that it has led to the vaccination being put on hold at their centres.
June 13, 2021
The Economic Times
Several private hospitals across the country said they have no clarity on procuring COVID-19 vaccines under the new policy announced by Prime Minister Narendra Modi and that it has led to the vaccination being put on hold at their centres.
June 13, 2021
The Economic Times
Several private hospitals across the country said they have no clarity on procuring COVID-19 vaccines under the new policy announced by Prime Minister Narendra Modi and that it has led to the vaccination being put on hold at their centres.
June 13, 2021
The Economic Times
Several private hospitals across the country said they have no clarity on procuring COVID-19 vaccines under the new policy announced by Prime Minister Narendra Modi and that it has led to the vaccination being put on hold at their centres.
Press Trust of India
June 13, 2021
@bsindia
Hospitals want a proper mechanism and a single-window system to be put in place for procurement of vaccine doses
June 10, 2021
Moneycontrol
With limits on purchases and the prices they can charge, private hospitals are assessing the impact on their COVID-19 vaccination drives
Chris Kay & P R Sanjai | Bloomberg
June 9, 2021
@bsindia
The worlds largest vaccine maker has been dogged by problems, from a ban on exports to a factory fire, that have hampered its ability to fill orders
June 7, 2021
NDTV.com
People going abroad for education, jobs or as part of Indian contingent for Tokyo Olympic, will have to get their CoWIN vaccination certificates linked to their passport.
June 7, 2021
NDTV.com
People going abroad for education, jobs or as part of Indian contingent for Tokyo Olympic, will have to get their CoWIN vaccination certificates linked to their passport.
FE Online
June 5, 2021
The Financial Express
Serum already has made supply commitments for World Health Organisation (WHO) backed COVAX for a billion doses and these will be made available as and well the Indian government allows.
June 4, 2021
NDTV.com
No decision on granting indemnity to any foreign or Indian Covid vaccine-manufactures has been taken yet, the government said Friday, underlining these decisions are to be taken "in the interest of nation and people".
June 4, 2021
India Today
DCGI granted Serum Institute of India permission to manufacture Sputnik V Covid vaccine in India on Friday. (Photo: File)
June 4, 2021
NDTV.com
No decision on granting indemnity to any foreign or Indian Covid vaccine-manufactures has been taken yet, the government said Friday, underlining these decisions are to be taken "in the interest of nation and people".
June 4, 2021
The Times of India
India News: NEW DELHI: The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik Covid-19 vaccine in India for examination,.
Press Trust of India
June 4, 2021
@bsindia
These decisions (on indemnity) are to be taken in totality in the interest of nation and in the interest of people, says NITI Aayog member (Health) Dr V K Paul
Press Trust of India
June 4, 2021
@bsindia
Russias Sputnik V vaccine is currently being manufactured by Dr Reddys Laboratories in India.
Leroy Leo
June 3, 2021
mint
Serum has been in talks with RDIF for a few months now to put in place a manufacturing agreement for the vaccine
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.